ReleaseWire Connect

Lung cancer can be broadly classified into two categories such as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Non-small cell lung cancer can be further classified into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Squamous non-small cancer develops from the cells lining the airways and is found near the center of the lungs in one of the main airways. Non-small cell lung cancer globally accounts for 85% to 90% of lung cancer, in which adenocarcinoma and squamous cell cancers are responsible for approximately 40% and 30%, respectively. Prominent symptoms of squamous non-small cell lung cancer include excessive coughing, wheezing and shortness of breath, chest pain, and occurrence of blood in sputum. Many physicians misunderstood this disease with collapsed lungs or pneumonia. The disease usually takes longer time to develop from confined tumors to invasive cancer. Primary diagnostic technique comprises sputum test, bronchoscopy, MRI scan, needle biopsy, and CT scan among others. In Australia, squamous non-small cell lung cancer is a common type of lung cancer accounting for 29% of total cases of lung cancer.

Prostate cancer is one of the most common types of cancer observed in men after skin cancer and is one of the leading causes of mortality in men. A prostatectomy catheter is used for the removal of urine from the bladder after a prostatectomy surgery. It is a thin, flexible, rubber tube placed in the bladder to drain the urine. At one end of the prostatectomy catheter, a balloon filled with water is provided which holds the catheter in place within the bladder. Urine flows out of the body through the urethra which is surrounded by the prostate gland. Various factors such as enlargement of the prostate gland, prostate cancer, or any treatment of prostate gland affect the normal process of the urination. Thus, these catheters are required to remove the urine from the body. A prostatectomy catheter is made from silicone which makes it soft and inert.

Key companies in the global subcutaneous immunoglobulin market include Grifols S.A., CSL Behring LLC, Shire Plc., Biotest AG, Kedrion S.p.A., Octapharma AG, Baxalta Incorporated, and Talecris Biotherapeutics, Inc. The global subcutaneous immunoglobulin market is likely to present an opportunity-filled landscape for new players in the coming years, while steady expansion efforts are likely to help existing market players consolidate their position in the subcutaneous immunoglobulin market.

Allergan plc and Novartis AG dominated the global Alzheimer's drugs market in 2016, their global market presence attributable to acquisitions of leading emerging brands. Other key players in the global Alzheimer's drugs market include Eisai Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Merz Holding GmbH & Co KG, and Johnson & Johnson.

Transparency Market Research (TMR) has announced the release of a new market study based on the global contrast media injectors market. According to the study, the market for contrast media injectors is growing at a CAGR of 5% from 2014 to 2020. The report focuses on the industry trends and key market forces that are benefitting the growth of the contrast media injectors market, and also the factors that restrain its growth.The report is titled "Contrast Media Injectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020." The report provides fruitful insights into the contrast media injectors market's structure and the market projections for contrast media injectors.

Transparency Market Research (TMR) has published a new report, titled "Deep Brain Stimulation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020".The report states that the global deep brain stimulation devices market for Parkinson's disease will expand at a CAGR of 11.0% during the forecast period from 2013 to 2019. In 2012, the global deep brain stimulation devices market for Parkinson's disease was worth US$4.5 bn and by 2019, it is projected to be worth US$9.4 bn.

Transparency Market Research (TMR) has announced the publication of a new market research report on the preimplantation genetic diagnosis. Statistics mentioned in the report suggest that the global preimplantation genetic diagnosis market was valued at US$77.2 million in 2013 and is expected to reach US$118.0 million by 2020, growing a CAGR of 6.28% from 2014 to 2020. The report, titled "Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", offers an in-depth understanding of the global preimplantation genetic diagnosis market, its growth drivers, market restraints, and potential growth opportunities in the coming future.

The global small bone and joint orthopedic devices market is largely consolidated, thereby limiting competition between the top three companies viz, Depuy Synthes, Wright Medical Group, and Zimmer Biomet Holdings Inc. These three companies accounted for 70% of the market collectively, in the year 2014, states a new report by Transparency Market Research (TMR). The wide range of product portfolios of these companies has helped these players gain a strong presence within the global small bone and joint orthopedic devices market. TMR, in its report recommends market players to focus on R&D so as to introduce innovative and advanced products at minimal cost. This will help them to gain a competitive edge. Expert analysts from TMR also suggest that manufacturers start focusing on the developing economies of Asia Pacific, as the future holds many growth opportunities in this region.

The global specialty medical chairs market has been foreseen by Transparency Market Research (TMR) to cover companies that could focus on the expansion of their distribution networks. Companies could be making efforts to strike tactical alliances with extensive distributors, private clinics, and multispecialty clinics. In the foreseeable future, companies have been anticipated to secure a strong foundation for increased sales in the global market by widening their distribution networks in order to extend their geographical foothold. DentalEZ, ACTIVEAID, Inc., and Fresenius SE & Co. KGaA could be among the leading companies in the market.

Although the top four players - Sigma-Aldrich, Thermo Fisher, Merck Millipore, and Becton, Dickinson and Co. - accounted for a share of 52.7% in the global market for microbiology culture in 2014, the presence of a large pool of international as well as regional players points toward a moderately fragmented structure of the market's competitive landscape, finds a report by Transparency Market Research (TMR). The degree of competition, however, is high within the market and participants are aggressively focused on making new discoveries and reaching new breakthroughs in order to gain a competitive edge.